Aortic Aneurysm Market Size – Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2034
Overview
The Aortic Aneurysm Market size was valued at USD 2.56 Billion in 2025 and the total Aortic Aneurysm revenue is expected to grow at a CAGR of 8.3% from 2026 to 2034, reaching nearly USD 5.26 Billion.
Aortic Aneurysm Market Overview:
An aortic aneurysm is a bulging in the wall of the aorta, the main blood vessel that delivers oxygen-rich blood from the heart to the rest of the body. Aortic aneurysms can develop in any part of the aorta and can be tube-shaped or circular. Internal bleeding or stroke can be life-threatening if an aortic aneurysm develops.
Aortic Aneurysm Market GrowthShare Analysis
To know about the Research Methodology :- Request Free Sample Report
Aortic Aneurysm Market Dynamics:
The rising prevalence of alcohol and tobacco consumption is the major driver for market growth.
The rising elderly population, poor eating habits, and the high incidence of Cardiovascular Diseases (CVDs) are some of the factors driving demand for novel therapies and equipment for thoracic and abdominal aneurysm repair, which is projected to propel the market forward. Smoking, which has become a worldwide issue, is also contributing to the market's growth. Due to a lack of information about the detrimental effects of smoking on health and the accompanying risk of developing an aneurysm, low- and middle-income nations, in particular, confront considerable issues about smoking. Regulatory and reimbursement circumstances differ depending on the region.
Growing technical advancements and medical research are some of the factors propelling the market forward.
Furthermore, the expansion of the Abdominal Aortic Aneurysm Treatment Market is aided by increased research and development activities, which aid in the creation of innovative medicines for a variety of ailments. The market's growth is being hampered by a scarcity of competent professionals and rising treatment costs.
Furthermore, lack of awareness and treatment availability is limiting the market's growth over the projection period. Continuous technological improvements in endovascular surgical techniques, on the other hand, are expected to boost the market growth in the coming years.
The report has profiled sixteen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.
Segment Analysis:
The Global Aortic Aneurysm Market is segmented on the basis of Type, Treatment and Product.
Based on Type, the Abdominal Aortic Aneurysm segment is anticipated to dominate the global market during the forecast period. The segment is expected to grow by registering a CAGR of 5.2% during forecast years. AAA is more frequent in the lower abdomen, with the majority of cases occurring in the infrarenal or juxtarenal regions of the lower abdomen. In comparison to thoracic aneurysms, the number of repairs performed for infrarenal and juxtarenal aneurysms is substantially higher in terms of volume.
The market is being driven by two key factors: an increasing geriatric population and technological innovation. Moreover, during the forecasted period, changing lifestyles and advancements in R&D activities would boost overall market demand for abdominal aortic aneurysm treatment. Bolton Medical acquired Vascutek in April 2018 in order to develop aortic and vascular treatments.
Based on Product, the stent-grafts segment held a significant market share in 2025. Because of technological breakthroughs in stent-graft design, it is predicted to grow at the fastest rate during the forecast period. Advanced stent graft systems, for example, are now available with built-in imaging and delivery catheters. The use of catheters for blood vessel expansion and occlusion, on the other hand, adds to the overall cost of treatment.
Regional Insights:
North America accounted for the dominant share in 2025.
The American region has the largest market share and is anticipated to maintain this position during the projection period. This can be ascribed to established healthcare infrastructure, ongoing technical breakthroughs, product developments, and an increase in the number of market player collaborations. Additionally, an increase in the prevalence of aortic aneurysm has come from an increase in the number of tobacco smokers, which is expected to fuel market expansion over the assessment period.
In the United States, for example, Medicare provides one abdominal aortic ultrasound for patients at risk. Due to technological developments and a high prevalence of atherosclerosis, Europe is expected to account for a large market share throughout the forecast period. The National Health Service (NHS) and the United States Food and Drug Administration (FDA) are attempting to reduce the occurrence of aortic aneurysm.
The report also helps in understanding the Global Aortic Aneurysm Market dynamics, structure by analyzing the market segments and project the Global Aortic Aneurysm Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Aortic Aneurysm Market make the report investor’s guide.
Aortic Aneurysm Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 09 July 2025 | W. L. Gore & Associates, Inc. | W. L. Gore & Associates secured CE Mark approval under European Medical Device Regulation (MDR) for an expanded indication of its GORE VIABAHN VBX Balloon Expandable Endoprosthesis as a dedicated bridging stent for branched and fenestrated endovascular aneurysm repair (BEVAR and FEVAR). | This provides European vascular surgeons with an on-label solution for complex aortic aneurysms involving renal and mesenteric arteries, significantly improving procedural precision and device patency in high-risk patients. |
| 14 October 2025 | Nurea | Nurea secured U.S. FDA 510(k) clearance for its AI-powered PRAEVAorta 2 software designed to deliver automated aortic diameter measurements from contrasted and non-contrasted CT scans. | The approval commercializes advanced AI diagnostic tools in the U.S. market, streamlining clinical workflows and enabling earlier detection and monitoring of abdominal aortic aneurysms while reducing health system costs. |
| 22 October 2025 | Medtronic | Medtronic received U.S. FDA labeling clearance for its Endurant Stent Graft System, incorporating clinical evidence for treating ruptured abdominal aortic aneurysms (rAAA) and removing previous rAAA warning labels. | This milestone makes Endurant the first stent graft with updated rAAA clinical labeling, giving clinicians expanded confidence to perform emergency endovascular repairs during life-threatening rupture events. |
| 16 March 2026 | Terumo Aortic | Terumo Aortic received U.S. FDA Breakthrough Device Designation for its custom-made Fenestrated TREO Abdominal Stent-Graft System designed for complex abdominal aortic aneurysms. | The designation expedites regulatory review for a highly customized EVAR technology, catering to patients with juxtarenal and suprarenal aneurysms who are ineligible for off-the-shelf endovascular devices. |
| 18 May 2026 | Artivion, Inc. | Artivion completed its full strategic acquisition of Endospan Ltd., gaining control of the NEXUS Aortic Arch Stent Graft System for off-the-shelf minimally invasive aortic arch repair. | The transaction broadens Artivion's complex endovascular portfolio, accelerating the global commercialization of specialized stent graft solutions for thoracic aortic diseases. |
| 07 July 2026 | W. L. Gore & Associates, Inc. | W. L. Gore & Associates received U.S. FDA approval for expanded labeling across the GORE EXCLUDER AAA Endoprosthesis and GORE EXCLUDER Conformable AAA Endoprosthesis product lines. | The regulatory update integrates real-world clinical registry data for ruptured aneurysm management, solidifying market adoption and expanding emergency endovascular repair access across U.S. vascular centers. |
Aortic Aneurysm Market Scope: Inquire before buying
| Global Aortic Aneurysm Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 2.56 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 8.3% | Market Size in 2034: | USD 5.26 Bn. |
| Segments Covered: | by Type | Thoracic Aortic Aneurysm (TAA) Abdominal Aortic Aneurysm (AAA) |
|
| by Treatment | Open Surgical Repair (OSR) Endovascular Aneurysm Repair (EVAR) |
||
| by Product | Stent Graft Catheter |
||
Aortic Aneurysm Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Aortic Aneurysm Market Key Players
1. Medtronic
2. W. L. Gore and Associates
3. Cook
4. Cardinal Health
5. Terumo Corporation
6. AbbVie Inc
7. Merck & Co., Inc
8. Lombard Medical, Inc
9. Boston Scientific Corporation
10.Cardiatis S.A
11.JOTEC GmbH
12.Endologix, Inc.
13.Endospan
14.LifeTech Scientific Corporation
15.Getinge AB
16.Arsenal Medical, Inc.
Frequently Asked Questions:
1. Which region has the largest share in Global Aortic Aneurysm Market?
Ans: North America region holds the highest share in 2025.
2. What is the growth rate of Global Aortic Aneurysm Market?
Ans: The Global Aortic Aneurysm Market is growing at a CAGR of 8.3% during forecasting period 2026-2034.
3. What is scope of the Global Aortic Aneurysm market report?
Ans: Global Aortic Aneurysm Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Aortic Aneurysm market?
Ans: The important key players in the Global Aortic Aneurysm Market are – Medtronic, W. L. Gore and Associates, Cook, Cardinal Health, Terumo Corporation, AbbVie Inc, Merck & Co., Inc, Lombard Medical, Inc, Boston Scientific Corporation, Cardiatis S.A, JOTEC GmbH, Endologix, Inc., Endospan, LifeTech Scientific Corporation, Getinge AB, Arsenal Medical, and Inc..
5. What was the Global Aortic Aneurysm Market size in 2025?
Ans: The Global Aortic Aneurysm Market size was USD 2.56 Billion in 2025.